Literature DB >> 16038880

Characterization of new D-beta-aspartate-containing proteins in a lens-derived cell line.

Takumi Takata1, Tadashi Shimo-Oka, Kunio Miki, Noriko Fujii.   

Abstract

Although proteins are generally composed of l-alpha-amino acids, biologically uncommon D-beta-aspartic acid (Asp)-containing proteins have been reported in various tissues from elderly individuals. Our previous study indicated that the N/N1003A cell line, derived from rabbit lens, includes D-beta-Asp-containing proteins of approximately 50 kDa by Western blot analysis of a 2D-gel using a polyclonal antibody that is highly specific for D-beta-Asp-containing proteins. In this study, we identified the D-beta-Asp-containing proteins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and the Mascot online database searching algorithm. The results indicate that one of these 50 kDa proteins is an enolase showing homology with tau-crystallin. Other D-beta-Asp-containing proteins, which we have recently discovered include lamin A/C, cytoplasmic NADP+-dependent isocitrate dehydrogenase, fructose-bisphosphate aldolase A, aldose reductase, L-lactate dehydrogenase A or calponin H2, phosphoglycerate mutase 1, phosphatidylethanolamine-binding protein, alpha-B-crystallin, and peptidyl-prolyl cis-trans isomerase A (PPlase).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038880     DOI: 10.1016/j.bbrc.2005.06.195

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Localization of D-β-aspartyl residue-containing proteins in various tissues.

Authors:  Ryota Motoie; Noriko Fujii; Shigeru Tsunoda; Kenji Nagata; Tadashi Shimo-Oka; Tadatoshi Kinouchi; Norihiko Fujii; Takeshi Saito; Koji Ono
Journal:  Int J Mol Sci       Date:  2009-04-29       Impact factor: 6.208

2.  In vivo substrates of the lens molecular chaperones αA-crystallin and αB-crystallin.

Authors:  Usha P Andley; James P Malone; R Reid Townsend
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.